Loading clinical trials...
Loading clinical trials...
A Double-blind, Randomized, Placebo-controlled Trial Evaluating The Safety And Efficacy Of Early Treatment With Eplerenone In Patients With Acute Myocardial Infarction
Conditions
Interventions
Eplerenone
Placebo
Locations
75
Canada
University of Alberta Hospital
Edmonton, Alberta, Canada
Walter C Mackenzie Health Sciences Centre (WCM)
Edmonton, Alberta, Canada
Diamond Health Care Centre (DHCC)
Vancouver, British Columbia, Canada
Vancouver General Hospital - Centennial Pavilion
Vancouver, British Columbia, Canada
Vancouver General Hospital, Vancouver Coastal Health Authority
Vancouver, British Columbia, Canada
Health Sciences Center, Eastern Health
St. John's, Newfoundland and Labrador, Canada
Start Date
September 1, 2010
Primary Completion Date
October 1, 2012
Completion Date
October 1, 2012
Last Updated
December 22, 2020
NCT06744322
NCT05198791
NCT07301034
NCT07257198
NCT06438315
NCT07444957
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions